Almac has announced that it is to perform the analytic phase of the AclarusDx diagnostic test for Exonhit.
The company's diagnostics business unit will also deliver the results of the analytic phase to Exonhit clinicians.
Exonhit AclarusDx is a microarray-based test that is intended to aid in the diagnosis of Alzheimer's disease (AD) by detecting biomarkers specific for AD in peripheral blood.
The test will be performed by Almac at its ISO17025-accredited laboratory.
